Miltefosine - The long-awaited therapy for visceral leishmaniasis?

被引:46
作者
Herwaldt, BL [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30341 USA
关键词
D O I
10.1056/NEJM199912093412411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1840 / 1842
页数:3
相关论文
共 10 条
[1]   The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei [J].
Croft, SL ;
Snowdon, D ;
Yardley, V .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) :1041-1047
[2]   Leishmaniasis - Public health aspects and control [J].
Desjeux, P .
CLINICS IN DERMATOLOGY, 1996, 14 (05) :417-423
[3]   Leishmaniasis [J].
Herwaldt, BL .
LANCET, 1999, 354 (9185) :1191-1199
[4]   Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis [J].
Jha, TK ;
Sundar, S ;
Thakur, CP ;
Bachmann, P ;
Karbwang, J ;
Fischer, C ;
Voss, A ;
Berman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (24) :1795-1800
[5]   HEXADECYLPHOSPHOCHOLINE - ORAL TREATMENT OF VISCERAL LEISHMANIASIS IN MICE [J].
KUHLENCORD, A ;
MANIERA, T ;
EIBL, H ;
UNGER, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1630-1634
[6]  
MURRAY HW, IN PRESS J INFECT DI
[7]   Epidemic visceral leishmaniasis in southern Sudan: Treatment of severely debilitated patients under wartime conditions and with limited resources [J].
Seaman, J ;
Mercer, AJ ;
Sondorp, HE ;
Herwaldt, BL .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (07) :664-672
[8]  
Sundar S, 1999, ANN TROP MED PARASIT, V93, P589, DOI 10.1080/00034989958096
[9]   Trial of oral miltefosine for visceral leishmaniasis [J].
Sundar, S ;
Rosenkaimer, F ;
Makharia, MK ;
Goyal, AK ;
Mandal, AK ;
Voss, A ;
Hilgard, P ;
Murray, HW .
LANCET, 1998, 352 (9143) :1821-1823
[10]  
*WHO, 1995, CONS M LEISHM HIV CO